Man Group
KURA icon

Man Group’s Kura Oncology KURA Stock Holding History

Man Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.86M Buy
475,027
+233,488
+97% +$2.01M 0.01% 1285
2025
Q4 		$2.51M Sell
241,539
-216,725
-47% -$2.27M ﹤0.01% 1371
2025
Q3 		$4.06M Sell
458,264
-64,124
-12% -$457K 0.01% 1151
2025
Q2 		$3.01M Buy
522,388
+366,324
+235% +$2.24M 0.01% 1261
2025
Q1 		$1.03M Buy
156,064
+137,359
+734% +$1.07M ﹤0.01% 1573
2024
Q4 		$163K Buy
+18,705
New +$269K ﹤0.01% 1897
2021
Q1 		– Sell
-17,158
Closed -$560K – 1927
2020
Q4 		$560K Sell
17,158
-7,418
-30% -$261K ﹤0.01% 1523
2020
Q3 		$753K Buy
24,576
+6,179
+34% +$136K ﹤0.01% 1446
2020
Q2 		$300K Buy
18,397
+4,687
+34% +$67.6K ﹤0.01% 1542
2020
Q1 		$136K Sell
13,710
-92,229
-87% -$1.06M ﹤0.01% 1498
2019
Q4 		$1.46M Sell
105,939
-147,446
-58% -$2.18M ﹤0.01% 1415
2019
Q3 		$3.84M Sell
253,385
-42,542
-14% -$757K 0.01% 991
2019
Q2 		$5.83M Buy
295,927
+198,870
+205% +$3.3M 0.02% 885
2019
Q1 		$1.61M Buy
+97,057
New +$1.5M 0.01% 1422

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's KURA Position: Q1 2026 in Review

Man Group increased its Kura Oncology (KURA) stake by 97% in Q1 2026, buying an estimated $2.01M and bringing the position to 475,027 shares worth $3.86M. The position accounts for 0.01% of the portfolio, ranked #1285.

Man Group first reported a position in KURA in Q1 2019 and has held it in 14 quarters since. The position peaked at $5.83M in Q2 2019. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Man Group held 475,027 shares of Kura Oncology worth $3.86M as of Q1 2026.
  • Man Group bought 233,488 Kura Oncology shares in Q1 2026, an estimated $2.01M.
  • Kura Oncology made up 0.01% of Man Group's portfolio in Q1 2026, its #1285 holding.
  • Man Group first reported a position in Kura Oncology in Q1 2019 and has held it in 14 quarters since.
  • Man Group's Kura Oncology position peaked at $5.83M in Q2 2019.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.